Menopause associated with increased prevalence of cardiovascular autonomic neuropathy in women with diabetes: this study

Published Date: 02 Mar 2023

Spain: A recent study showed an increase in subclinical autonomic neuropathy (CAN) in women aged 1...

Read Full News

Latest News

New Breathalyzer Detects When Your Body Is Burning Fat

A hand-held device that measures acetone levels in your breath — signaling ketosis — matched mass spectrometry tests for accuracy. But clinical uses may be limited for now.

Over-the-Counter Continuous Glucose Monitors: Okay for Kids?

A pediatric endocrinologist raises questions about use in youth without diabetes.

One Ultrasound Scan Flags Both MASH and Liver Scarring

A novel ultrasound-derived score combined with liver stiffness measurement can identify both MASH and fibrosis, potentially reducing the need for biopsy.

Surprising Signal for Semaglutide in Bipolar Disorder

The GLP-1 semaglutide was linked to fewer psychiatric hospitalizations in patients with bipolar disorder, raising the possibility of benefits beyond weight loss and glycemic control.

Lumbar CT Surpasses MRI in Vertebral Bone Quality Assessment

Lumbar CT attenuation measurements outperform MRI-derived vertebral bone quality scores for diagnosing osteopenia and osteoporosis in degenerative spinal populations.

Traditional Chinese Medicines Plus Metformin Improve A1c

In a phase 3 trial, adding a combo of two traditional Chinese meds to metformin reduced A1c and improved lipid measure in patients with T2D whose glycemic control was inadequate with metformin alone.

Todays Updates

Milvexian Fails to Reduce CV Events After ACS

Patients in the phase 3 LIBREXIA ACS trial showed no reduction in cardiovascular events after acute coronary syndrome.

Atorvastatin Cuts Major CV Events by 30% in Older Adults in STAREE

Statin use for primary cardiovascular prevention in adults aged 70 years or older is supported by data from STAREE, although treatment did not prolong disability-free survival.

Phase 3 Eplontersen Trial Results Disappoint

Despite a major reduction in transthyretin amyloid deposits, eplontersen, a drug that reduces TTR production, did not reduce events associated with TTR amyloidosis in a phase 3 trial.

Todays Updates

Milvexian Fails to Reduce CV Events After ACS

Patients in the phase 3 LIBREXIA ACS trial showed no reduction in cardiovascular events after acute coronary syndrome.

Atorvastatin Cuts Major CV Events by 30% in Older Adults in STAREE

Statin use for primary cardiovascular prevention in adults aged 70 years or older is supported by data from STAREE, although treatment did not prolong disability-free survival.

Phase 3 Eplontersen Trial Results Disappoint

Despite a major reduction in transthyretin amyloid deposits, eplontersen, a drug that reduces TTR production, did not reduce events associated with TTR amyloidosis in a phase 3 trial.

Latest News

A hand-held device that measures acetone levels in your breath — signaling ketosis — matched mass spectrometry tests for accuracy. But clinical uses may be limited for now.

A pediatric endocrinologist raises questions about use in youth without diabetes.

A novel ultrasound-derived score combined with liver stiffness measurement can identify both MASH and fibrosis, potentially reducing the need for biopsy.

The GLP-1 semaglutide was linked to fewer psychiatric hospitalizations in patients with bipolar disorder, raising the possibility of benefits beyond weight loss and glycemic control.

Lumbar CT attenuation measurements outperform MRI-derived vertebral bone quality scores for diagnosing osteopenia and osteoporosis in degenerative spinal populations.

In a phase 3 trial, adding a combo of two traditional Chinese meds to metformin reduced A1c and improved lipid measure in patients with T2D whose glycemic control was inadequate with metformin alone.

News All Time

FDA OKs Gene Therapy for Glycogen Storage Disease Type Ia

The FDA grants accelerated approval for the innovative, one-time gene therapy Genglycos to treat the rare disease GSDIa in children aged 8 years and older and adults.

Does Telehealth-Only GLP-1 Care Fall Short?

Many vital tests and evaluations a patient needs before and after starting GLP-1s can’t be done over the computer.

Partner Weight Loss Increases When Included in Program

A behavioral weight-loss program aimed at one partner can produce meaningful, lasting weight loss in the other — despite never asking them to change their own habits.

Fatigue, Brain Fog Persist in Women With Prolactinoma

Even with prolactin levels under control, many women with a prolactinoma still battle fatigue and concentration problems, a new Dutch cohort study reveals.

Is There a ‘Best’ GLP-1 Injection Site?

Experts say any of the three approved subcutaneous injection sites for GLP-1s will work, but users, and some social media influencers, have strong opinions about which is best.

More US Employers to Drop Weight-loss Drugs in 2027, as Healthcare Costs Increase

About 14% of employers in the United States have already or plan to drop GLP-1 drugs in 2027, as companies see ⁠rising healthcare costs, according to a survey released on...

Trump's Weight; Fauci Gets a Legal Defense Fund; Eye Drops Recalled

— Health news and commentary gathered by MedPage Today staff

Recognizing Patients With High Risk T1D: Clinical Indicators of IAH and Recurrent Severe Hypoglycemia

Recognizing Patients With High Risk T1D: Clinical Indicators of IAH and Recurrent Severe Hypoglycemia

Foundations and Frontiers in Acromegaly: Pathophysiology, Current Treatments, and Emerging SRLs

Foundations and Frontiers in Acromegaly: Pathophysiology, Current Treatments, and Emerging SRLs

Judge Questions Hegseth's Testosterone Policy Amid Military's Transgender Care Ban

Parties ordered to address "similarities and differences in administering TRT" to both groups

FDA Panel Endorses Lifting Restrictions on Peptides Backed by RFK Jr.

Votes go against agency scientists' recommendation to keep them off the compounding list

1,300 Dead in Outbreak; Cyclospora Response 'Mismanaged'? GLP-1 Access in Medicaid

Health news and commentary gathered by MedPage Today staff

Even Short Bouts of Antipsychotics Linked to Diabetes Risk

Risks rose through year 5 in youths, but were seen after even just 1 year

Surgery Underused for Primary Hyperparathyroidism With End-Organ Damage, Study Says

Large study highlights gap between guidelines and clinical practice

Thyroid Meds Recalled Nationwide; Worst GLP-1 for Hair Loss? PMOS Prevalence

News and commentary from the endocrinology world

Florida Investigates Fauci; Obesity Drug Trial Sparks Lawsuit; 'Early Bird' Dinners

Health news and commentary gathered by MedPage Today staff

Recommended News For You

Researchers identify potential new therapeutic targets for treating T-cell lymphoma and natural killer cell tumors.

In a randomized trial, the kinder, gentler regimen for classical Hodgkin wins out.

Novel Psychedelic Promising on Resistant Depression

Blinatumomab Plus Chemotherapy New Standard for Children With B-Cell ALL

Junk Food & Prostate Cancer; 'Office' Star's Stage IV Diagnosis; New Cancer Cluster?

Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?

New imaging guidelines for head and neck cancers, a step toward practice change

Recommended Articles For You

How AI, Multi-Omics, and Real-World Evidence are Redefining Oncology Research and Shaping Cancer Care? 

Hypogammaglobulinemia: A Comprehensive Guide for Patients and Caregivers 

Paving the Path to Precision: A Review of TAR-200 in the Evolving Bladder Cancer Landscape 

Neonatal Hematopoietic Transition and Blood Cell Maturation 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Independent Risk Factors for "Deaths of Despair" Found.

2.

New imaging probe helps track prostate cancer and possibly treat it before resistance develops

3.

Proton Therapy Fails to Beat IMRT in Prostate Cancer

4.

Infection Burden High With Myeloma T-Cell Therapies

5.

PPI, Antibiotics May Curb Durvalumab Efficacy in NSCLC

1.

Genomic Control of Erythropoietic Stem Cell Renewal

2.

Case-Based Learning on Unexpected Cytopenia Patterns Following Advanced Therapies

3.

Subchorionic Hematoma: Causes, Symptoms, and Treatment 

4.

Clonal Hematopoiesis as a Mechanism of Age-Related Disease

5.

Transformative Insights in Oncology in Daily Practice

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Innovations in Hematology

2.

Case-Based Learning: Oncology

3.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion

4.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion

5.

Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot